Brind.

Doug Ingram was appointed Chief Executive Officer of Sarepta on August 21, 2025.

3 reports, 3 independent Updated Jul 27
Gone quiet Reached 2 outlets in its first 24 hours
Reports
3
Developments
3
Repetition
0%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Doug Ingram was appointed Chief Executive Officer of Sarepta on August 21, 2025.

Who's involved

What this event is mainly about
Doug IngramSarepta

How it developed

Newest first. Tap a step to see who reported it.
  1. Doug Ingram is retiring from Sarepta Therapeutics, and Severino will succeed him as CEO. Severino has extensive experience in the industry.1 source
  2. Doug Ingram takes over as CEO of Sarepta.1 source
  3. Sarepta announced the use of Arrowhead's drug platform.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • yahoo.comSarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
  • Business WireSarepta Therapeutics Announces Refinancing of Approximately $700 Million of 1.25% Convertible Senior Notes due 2027 - Sarepta entered into exchange agreements with a limited number of holders of its
  • BloombergSarepta Gets Breathing Room in $700 Million Debt Restructure (Bloomberg) -- Sarepta Therapeutics Inc. landed a deal with investors to restructure around $700 million of debt, giving the company a rep